We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Trends in Combination Antipsychotic Use Among Persons With Commercial Insurance: A Data Snapshot.
- Authors
CITROME, LESLIE; GUO, ZHENCHAO; KALSEKAR, IFTEKHAR; FORBES, ROBERT A.; HEBDEN, TONY
- Abstract
In this data snapshot, the IMS PharMetrics Database was examined to assess the prevalence of combination antipsychotic therapy for the years 2003 through 2009 among 122,349 commercially insured adult individuals with bipolar disorder, depression, or schizophrenia. Although all three diagnostic groups were associated with varying amounts of combination antipsychotic use that included aripiprazole, olanzapine, quetiapine, risperidone and ziprasidone, persons with schizophrenia exhibited the highest rates. These findings indicate that from the perspective of "practice-based evidence," providers see value in combination therapy.
- Subjects
ANTIDEPRESSANTS; MENTAL depression; DRUG therapy for schizophrenia; ANTIPSYCHOTIC agents; COMBINATION drug therapy; DRUG utilization; DRUG prescribing; HEALTH insurance; BIPOLAR disorder; PHYSICIAN practice patterns
- Publication
Innovations in Clinical Neuroscience, 2012, Vol 9, Issue 3, p17
- ISSN
2158-8333
- Publication type
Article